Arthritis & Rheumatology

Article	Citations
Consideration of confounders, accuracy of diagnosis, and disease severity in assessing the risk of inflammatory bowel disease in patients with psoriasis and psoriatic arthritis/ankylosing spondylitis	600
A probable ecologic bias in the article on the progression of knee osteoarthritis: comment on the article by Lo et al	485
Lupus Interference With B Cell Tolerance Across the Developmental Continuum	351
Reply	348
Journal Club	205
Clinical Images: A lupus patient with multiple lichenoid papules	188
Expert Perspective: Management of Relapses in Giant Cell Arteritis	174
Reply	168
Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus	136
Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis	136
Sacroiliac Bone Marrow Edema: Innocent Until Proven Guilty?	129
Reset of Inflammatory Priming of Joint Tissue and Reduction of the Severity of Arthritis Flares by Bromodomain Inhibition	126
Sustained IFN Signature Suppression with Anifrolumab in a SAVI patient Refractory to JAK Inhibitor and Dazukibart Therapy	124
Nociplasticity: A Proposed Concept to Understand the Symptomatology of Systemic Lupus Erythematosus	122
Correction to CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus	121
Nociplastic pain: the wolf in sheep's clothing. Comment on the article by Sunzini et al	121
In This Issue	114
Reply	113
Does complement play a role in pathogenic ACPA?	110
No differences in myocardial perfusion between treatment‐naive, early rheumatoid arthritis patients and healthy controls	103
Recreational Physical Activity and Risk of Incident Knee Osteoarthritis: An International Meta‐Analysis of Individual Participant–Level Data	101
Alcohol Consumption and Risk of Total Hip Replacement Due to Hip Osteoarthritis in Women	100
Issue Information ‐ General Info	97
Potential residual confounders in an analysis of lifestyle factors and risk of incident systemic lupus erythematosus: comment on the article by Choi et al	97
Reply	93

Clinical Connections	88
Inhibiting the Inhibitor in Synovial Macrophages and Cancer Immunotherapy–Associated Inflammatory Arthritis	87
Air Pollution, Genetic Susceptibility, and Risk of Incident Systemic Lupus Erythematosus: A Prospective Cohort Study	85
Interleukin‐13 Receptor α1–Mediated Signaling Regulates Age‐Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis	83
In This Issue	82
Reply	82
Arthritis & Rheumatology: “Mid‐Term” Report	81
Issue Information ‐ General Info	81
Reply	76
Cardiovascular and Renal Morbidity in Takayasu Arteritis: Comment on the Article by Goel et al	75
Outcomes and Western Ontario and McMaster Universities Osteoarthritis Index Score Reporting in a Trial of the Efficacy and Safety of Diclofenac–Hyaluronate Conjugate: Comment on the Article by Nishida	72
	69
Altered Risk of Incident Gout According to Changes in Metabolic Syndrome Status: A Nationwide, Population‐Based Cohort Study of 1.29 Million Young Men	68
Antibodies to Neutrophil Extracellular Traps: Novel Markers for the Antiphospholipid Syndrome	68
Journal Club	67
Journal Club	62
	60
Clinical Connections	58
In This Issue	58
	57
Seronegative palindromic rheumatism: what are we talking about? Comment on the article by Yang et al	56
The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era	56
Clinical Connections	56
Limitations in the real‐world emulation of the HORIZON‐Pivotal Fracture Trial: comment on the article by D'Andrea et al	51
	51
	50
Issue Information	50
Targeting the Myddosome in Systemic Autoimmunity: Ready for Prime Time?	50
Lung Inflammation, NETosis, and the Pulmonary Initiation of Anti–Citrullinated Protein Antibody Response: What Came First, the Chicken or the Egg?	48
Concerns Regarding the Analysis of a Takayasu Arteritis Cohort: Comment on the Article by Goel et al	48
Anti–Cytosolic 5′‐Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis	47
Reply	46
Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial	46
Issue Information ‐ General Info	46
Reply	45
The importance of rigorous methods in observational comparative effectiveness studies of rare diseases: comment on the article by Ruperto et al	45
Reply	45
Factors influencing severe COVID‐19 in systemic vasculitis patients: comment on the article by Rutherford et al	45
Fanning the Flames of Autoimmunity: The Microbiome in Rheumatic Disease	45
B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis	44
Possible confounding factors explaining data on heart failure risk in patients with polymyositis/dermatomyositis: comment on the article by Lin et al	44
Biologics for Eosinophilic Granulomatosis With Polyangiitis—One Size Does Not Fit All: Comment on the Article by Canzian et al	44
Reply	44
Effect of Clonally Expanded PD‐1highCXCR5–CD4+ Peripheral T Helper Cells on B Cell Differentiation in the Joints of Patients With Antinuclear Antibody–Positive Juvenil	44
In This Issue	43
Clinical Connections	43
Few Adverse Cardiovascular Events Among Patients With Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured?	43
Mediation of the Same Epigenetic and Transcriptional Effect by Independent Osteoarthritis Risk–Conferring Alleles on a Shared Target Gene, COLGALT2	42
Using Mice to Model Human Osteoarthritis: Age, Biologic Sex, and Pain Matter	41
Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease Course	40

NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2‐Mediated Pyroptosis Through the Phosphorylated Salt‐Inducible Kinase 1/Sterol Regulatory Element Binding T	40
Higher alcohol consumption was associated with greater incidence of total hip replacement due to hip osteoarthritis in a dose‐dependent manner in women: comment on the article by Marchand et al	39
	39
	39
Journal Club	39
Clinical Connections	39
In This Issue	38
Journal Club	38
A diagnostic performance study of the 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis in a cohort of patients presenting with suspected giant ce	38
Effect of the methotrexate discontinuation for 1 versus 2 weeks on vaccine response to seasonal influenza vaccine in rheumatoid arthritis: a noninferiority randomized controlled trial	38
	38
Journal Club	37
Pregnancy outcomes in women with psoriatic arthritis: comment on the article by Remaeus et al	37
Criteria for Hyperinflammation Developing in COVID‐19: Analysis of 2 Cohorts From Different Periods of the Pandemic	37
In This Issue	36
Clinical Connections	36
Clinical Images: Optic perineuritis in relapsing granulomatosis with polyangiitis	36
In This Issue	35
At the Heart of Treating Kawasaki Disease: The Search for New Approaches to Prevent Coronary Artery Aneurysms	35
Issue Information	35
Association of change in metabolic syndrome status with altered risk of incident gout: comment on the article by Eun et al	35
Reply	34
Issue Information ‐ General Info	34
Clinical Images: Hydroxyurea‐induced dermatomyositis‐like rash	34
Clinical Images: Intraosseous calcification migration: journey to the center of the bone	34
On the perils of peeking into the future: comment on the article by Rosenthal et al	34
Clinical Connections	34
Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study	33
In This Issue	33
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients	33
Journal Club	33
Journal Club	33
Issue Information ‐ General Info	33
Povetacicept, an Enhanced DualAPRIL/BAFFAntagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell–Related Autoimmune Disea	33
Bilateral Calf Hypertrophy With Increased Muscle Enzyme Levels	32
Pregnancy Outcomes in Women With Psoriatic Arthritis in Relation to Presence and Timing of Antirheumatic Treatment	32
Journal Club	31
Differences in definitions and prevalence of hand osteoarthritis: comment on the article by Eaton et al	30
Tissue‐Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis	30
Prediction of Psoriatic Arthritis in Patients With Psoriasis Using DNA Methylation Profiles	30
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS–CoV‐2 Messenger RNA Vaccination	30
Optimal bridging strategy in active early rheumatoid arthritis: a bridge falling short? Comment on the article by Krause et al	30
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study	30
The risk of venous thromboembolism increases within one month of gout flare: comment on the article by Cipolletta et al	29
Journal Club	29
Clinical Images: Rice bodies in pseudogout	29
Pyrin Inflammasome Activation Abrogates Interleukin‐1 Receptor Antagonist, Suggesting a New Mechanism Underlying Familial Mediterranean Fever Pathogenesis	29
Reply	29
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2	29
Issue Information	29
Clinical Connections	28
Correction to: Discovery of a Novel Missense Variant in NLRP3 Causing Atypical Cryopyrin‐Associated Periodic Syndromes With Hearing Loss as the Primary Presentation, Responsive to Anti‐Inte	28
Myositis‐Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality	28
CCL19‐Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase	28
More Considerations for Risk Stratification of Fetal Atrioventricular Block Beyond Anti‐Ro Titer: comment on the article by Buyon et al	28
Reduced Cortico‐Cortical Resting‐State Connectivity in Sensory Systems Related to Bodily Pain in Juvenile Fibromyalgia	27
Identification of Shared and Asian‐Specific Loci for Systemic Lupus Erythematosus and Evidence for Roles of Type III Interferon Signaling and Lysosomal Function in the Disease: A	27
Contribution of Interleukin‐4–Induced Epithelial Cell Senescence to Glandular Fibrosis in IgG4‐Related Sialadenitis	27
The Devil Is in the Detail: Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty	27
Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome	27
Molecular Signatures of Kidney Antibody–Secreting Cells in Lupus Patients With Active Nephritis Upon Immunosuppressive Therapy	27
Clinical Images: Painless subcutaneous swellings in a middle‐aged man	27
Relationship Between Rheumatoid Arthritis and Pulmonary Function Measures on Spirometry in the UK Biobank	27
Brain Structural Changes During Juvenile Fibromyalgia: Relationships With Pain, Fatigue, and Functional Disability	27
Criteria for the pathogenicity of anticentromere (anti–CENP‐B) autoantibodies in systemic sclerosis: comment on the article by van Leeuwen et al	26
An imperfect world: assessing safety of biological treatments in systemic lupus erythematosus. Comment on the article by Materne et al	26
A methodologic problem and a conceptual issue related to the new 2022 antineutrophil cytoplasmic antibody–related vasculitis criteria sets: comment on criteria sets approved by the American College of	26
Low levels of anti–SARS–CoV‐2 antibodies after vaccination in rituximab‐treated patients: comment on the article by Simon et al	26
Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia	26
Erosive Hand Osteoarthritis: Incidence and Predictive Characteristics Among Participants in the Osteoarthritis Initiative	26
Anti‐Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis	26
The Relationship of Pain Reduction With Prevention of Knee Replacement Under Dynamic Intervention Strategies	26
Clinical Connections	26
Alterations of the Primary Cilia Gene SPAG17 and SOX9 Locus Noncoding RNAs Identified by RNA‐Sequencing Analysis in Patients With Systemic Sclerosis	25
Minimal tofacitinib dose for maintenance in axial spondyloarthritis: real‐world data from a resource‐limited setting	25
Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and Treatment	25
Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti‐Transcriptional Intermediary Factor 1γ Juvenile‐Onset Dermatomyositis	25
Association of Bone Erosions and Osteophytes With Systemic Bone Involvement on High‐Resolution Peripheral Quantitative Computed Tomography in Premenopausal Women With Longstanding Rheumatoi	25
Clinical Images: Hairy kidney in IgG4‐related disease	25
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Tr	25

Clinical Connections	24
Complement C4, the Major Histocompatibility Complex, and Autoimmunity	24
Role of PD‐L1 in Arthritis: Comment on the Article by Wood et al	24
Anti‐S100A4 monoclonal antibody treatment ameliorates experimental skin fibrosis and SSc‐specific transcriptional signatures in human skin: Comment on the targeting S100A4 is hel	24
Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis	24
Clinical Images: Detection of titanium dioxide particles by Raman spectroscopy in synovial fluid from a swollen ankle	24
COVID‐19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings	24
The dysbiosis of the gut microbiome in spondyloarthritis patients is correlated with both disease activity and HLA‐B27 status	24
Pulmonary Damage Biomarkers for Risk of Rheumatoid Arthritis–Associated Interstitial Lung Disease: Enabling Early Detection and Risk Stratification	24
International Consensus for the Dosing of Corticosteroids in Childhood‐Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis	24
American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision	24
Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids	24
Association of Muscle Quality and Pain in Adults With Symptomatic Knee Osteoarthritis, Independent of Muscle Strength: Findings From a Cross‐Sectional Study	24
Mechanistic Target of Rapamycin Inhibition Prevents Coronary Artery Remodeling in a Murine Model of Kawasaki Disease	24
Clinical Connections	24
Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyropho	23
Genetic Liability to Rheumatoid Arthritis in Relation to Coronary Artery Disease and Stroke Risk	23
Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide	23
Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial	23
Erratum	23
Reply	23
Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus	23
Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention	23
Issue Information	23
Erratum	23
Interleukin‐1β–Activated Microvascular Endothelial Cells Promote DC‐SIGN–Positive Alternatively Activated Macrophages as a Mechanism of Skin Fibrosis in Systemic Sclerosis	23
Airway obstruction as a pulmonary manifestation of rheumatoid arthritis: comment on the article by Prisco et al	23
Corrigendum	23
Sex Differences in B Cells from the Joints of Children with Oligoarticular Juvenile Idiopathic Arthritis	22
Functional Genomic Analysis of a RUNX3 Polymorphism Associated With Ankylosing Spondylitis	22
Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of Osteoarthritis	22
Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy	22
Association of Circulating Antibody‐Secreting Cell Maturity With Disease Features in Primary Sjögren's Syndrome	22
TLR7/8 Activation in Immune Cells and Muscle by RNA‐Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis	22
Non‐Redundant Roles of T Cell Costimulation Pathways in Inflammatory Arthritis Revealed by Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN‐101)	22
Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et al.	22
Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Co	22
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placeb	22
Association Study Identified HLA‐DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus‐Associated Pulmonary Arterial Hypertension	22
Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality	22
Reply to Letter to the Editor	22
Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis	22
Differences in the Oral Microbiome in Patients With Early Rheumatoid Arthritis and Individuals at Risk of Rheumatoid Arthritis Compared to Healthy Individuals	22
Identification of a Distinct Monocyte‐Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune Cells	21
Contribution of MicroRNA‐27b‐3p to Synovial Fibrotic Responses in Knee Osteoarthritis	21
2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis	21
Comparative Effectiveness of Rituximab‐ Versus Cyclophosphamide‐Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis for the Risk of Kidney Fail	21
Association of Sputum Neutrophil Extracellular Trap Subsets With IgA Anti–Citrullinated Protein Antibodies in Subjects at Risk for Rheumatoid Arthritis	21
CD163+ M2 Macrophages Promote Fibrosis in IgG4‐Related Disease Via Toll‐like Receptor 7/Interleukin‐1 Receptor–Associated Kinase 4/NF‐κB Signalin	21
Abstract Supplement ACR Convergence 2021	21
Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares	21
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis	21
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population‐Based Study Over Four Decades Using the Lupus Midwest Network	21
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases	21
Anti‐Gephyrin Antibodies: A Novel Specificity in Patients With Systemic Sclerosis and Lower Bowel Dysfunction	21
SH2 Domain–Containing Phosphatase 2 Inhibition Attenuates Osteoarthritis by Maintaining Homeostasis of Cartilage Metabolism via the Docking Protein 1/Uridine Phosphorylase 1/Uridine Cascade	21
Identification of Three Different Phenotypes in Anti–Melanoma Differentiation–Associated Gene 5 Antibody–Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstit	21
METTL14‐Mediated m6A Modification of TNFAIP3 Involved in Inflammation in Patients With Active Rheumatoid Arthritis	21
Poly‐Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes	21
Imaging Mass Cytometry Reveals Predominant Innate Immune Signature and Endothelial–Immune Cell Interaction in Juvenile Myositis Compared to Lupus Skin	21
Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis	20
Therapeutic Effect of Cyclin‐Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis	20
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5	20
IgG Anti–Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross‐Sectional Study Encompassing ~1,500 Samples	20
2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis	19
The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease	19
Noncanonical Pyroptosis Triggered by Macrophage‐Derived Extracellular Vesicles in Chondrocytes Leading to Cartilage Catabolism in Osteoarthritis	19
Mitigation of Osteoclast‐Mediated Arthritic Bone Remodeling By Short Chain Fatty Acids	19
Fractures in Patients With Acute Calcium Pyrophosphate Crystal Arthritis Versus Matched Comparators in a Large Cohort Study	19
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial	19
Osteoarthritis Care and Risk of Total Knee Arthroplasty Among Medicare Beneficiaries: A Population‐Based Study of Regional Covariation	19
Expert Perspective: An Approach to Refractory Lupus Nephritis	19
Association of Combined Anti‐Ro52/TRIM21 and Anti‐Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation	19
The Interleukin‐1 Receptor–Associated Kinase 4 Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial	19
Greater Somatosensory Afference With Acupuncture Increases Primary Somatosensory Connectivity and Alleviates Fibromyalgia Pain via Insular γ‐Aminobutyric Acid: A Randomized Neuroimaging Trial	19
Vitamin D and Marine n‐3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double‐Blind, Placebo‐Controlled Trial	19
Phase III/IV, Randomized, Fifty‐Two–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus	19
Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial	19
Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis	19
Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta‐Analysis of the Control Arms of Random	18
Joseph D. Croft Jr, MD, 1936‐2024	18
Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthr	18
The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population‐Based Study	18
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis	18
Induction of Interferon‐γ and Tissue Inflammation by Overexpression of Eosinophil Cationic Protein in T Cells and Exosomes	18
Rituximab Impairs B Cell Response But Not T Cell Response to COVID‐19 Vaccine in Autoimmune Diseases	18
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis	18
Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue‐Engineered Scleroderma Epidermis	18
Expansion of Fcγ Receptor IIIa–Positive Macrophages, Ficolin 1–Positive Monocyte‐Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in	18
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis	18
Reply	18
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project	18
Knee Alignment Correction by High Tibial Osteotomy Reduces Symptoms and Synovial Inflammation in Knee Osteoarthritis Accompanied by Macrophage Phenotypic Change From M1 to M2	18
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria	18
Reliability and Diagnostic Accuracy of Radiography for the Diagnosis of Calcium Pyrophosphate Deposition: Performance of the Novel Definitions Developed by an International Multidisciplinary Working G	18